• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PDN

PALADIN ENERGY LTD - News & Media

2.00% ! $6.38
Market Cap $2.546B  !
Metals & Mining Industrial Metals & Minerals
Add to My Watchlist

Paladin Energy Ltd is an Australia-based independent uranium producer with 75% ownership... Paladin Energy Ltd is an Australia-based independent uranium producer with 75% ownership of the Langer Heinrich Mine (LHM) located in Namibia. The Company also owns a portfolio of uranium exploration and development assets in the mining jurisdictions of Canada and Australia. Its segments include Australia, Namibia and Canada. The LHM is located in central western Namibia, approximately 80 kilometers (km) east of Swakopmund and 85 km northeast of the Walvis Bay deepwater harbor. Its Patterson Lake South (PLS) Project hosts the Triple R deposit, a high-grade and near-surface uranium deposit. The property comprises over 49 claims covering approximately 57,622 hectares. It owns a number of greenfield exploration projects that are prospective for hosting high-grade uranium, including West Cluff, Larocque, Seahawk, Merlin, Corsair and Typhoon. Its projects also include Michelin (Labrador, Canada), Mount Isa and Manyingee projects in both Queensland and Western Australia.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Articles & Videos

Paladin sinks over -9% as holders mull lofty Langer Heinrich uranium estimates

Paladin Energy (ASX:PDN) has shaved nearly a tenth of its company value on Wednesday morning, with the -9.8% price dive coming on the heels of a lofty uranium production goal set by the company in its latest quarterly.Listen to the HotCopper podcast for in-depth discussions and insights on all th...

23 Jul 2025 10:50 (AEST)

'Decades of future development opportunities' ahead for Paladin after plant improvement works

Paladin Energy Ltd recorded uranium production broadly in line with yearly expectations, despite a fall back in the December quarter

22 Jan 2025 10:29 (AEDT)

Paladin Energy puts Christmas bow on $1.5B all-scrip Fission Uranium merger

Paladin Energy (ASX:PDN) has completed the acquisition of Fission Uranium Corp six months after the $1.5 billion merger deal originally began, with the all-scrip deal netting final clearance just before the Christmas break.News came last week that Canadian regulators had green-lit the deal after ...

24 Dec 2024 10:41 (AEDT)

Regulator approves Paladin's acquisition of TSX-listed Fission Uranium

Paladin Energy (ASX:PDN) has seen its shares defy a red Thursday and jump slightly on news Canada's allowing its buyout of Fission Uranium.

19 Dec 2024 14:07 (AEDT)

Paladin cuts back uranium production guidance for FY25 based on hiccups at Langer Heinrich

Paladin Energy Ltd has cut back its guidance for uranium production in the 2025 fiscal year, based on challenges to ramp up at the mine

12 Nov 2024 09:42 (AEDT)

Canada orders national security review over CGN's 11.26% opposition to Paladin-Fission deal

Paladin has disclosed its attempted takeover of Fission Uranium Corp was blocked by a Chinese shareholder late last month.

02 Oct 2024 09:56 (AEST)

Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance

Uranium player Paladin Energy (ASX:PDN) has revealed it expects to produce up to 4.5Mlbs of uranium through FY25.

27 Jun 2024 09:28 (AEST)

Paladin kicks off uranium production in Namibia

Paladin Energy has produced commercial uranium for the first time at its Langer Heinrich mine in Namibia.

02 Apr 2024 12:07 (AEDT)

Paladin Energy executes US$150m syndicated debt facility

Paladin Energy (ASX:PDN) has executed a US$150 million (A$228 million) syndicated debt facility.

25 Jan 2024 11:38 (AEDT)



Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$6.38 		Change
-0.130(2.00%) 		Mkt cap ! $2.546B
Open High Low Value Volume
$6.45 $6.60 $6.36 $29.29M 4.548M

Buyers (Bids)

No. Vol. Price($)
2 3548 $6.38
 

Sellers (Offers)

Price($) Vol. No.
$6.40 7106 1
View Market Depth
Last trade - 16.19pm 30/07/2025 (20 minute delay) ?
Last
$6.40 		  Change
-0.130 ( 1.27 %)
Open High Low Volume
$6.43 $6.60 $6.36 602767
Last updated 15.59pm 30/07/2025 ?
PDN (ASX) Chart

Top Stories

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

The ASX200 rebounded today and was in the green heading into the close. Investors were buoyant in response to positive inflation data that increased the odds of an interest rate cut in August.Staples, Real Estate and Discretionary were the strongest performing sectors. Utilities and IT were a dra...
Haranga jumps +7% on Lincoln acquisition Haranga Resources (ASX:HAR) has spiked in intra-day trade after closing the acquisition of the Lincoln Gold Project in California.The Lincoln Project traverses 322 hectares and covers a strike length of the Mother Lode with 5.8km between Sutter Creek and Amador City. It boasts a gold resource of ...
Ionic Rare Earths falls -7% as momentum slips on vague production update Ionic Rare Earths (ASX:IXR) @ a well-known and much-loved rare earths darling on something of a comeback run lately @ has slipped -7%, presumably as the market digests what a vague update released on Wednesday actually means. According to the company, @urgent supply requests from US, European and...
HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic Let’s check in with what HotCopper users are closely watching at lunchtime. Given that we’re basically on the deadline before companies get a scolding if they don’t report updates, on Wednesday, the ASX announcements list is basically one big wall o...
Neurizon inks $1.5M loan against R&D Tax Rebate Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.